Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 192
Last updated 2017-05-09
Summary
Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this trial is to evaluate aspects of treatment response in cocaine dependent individuals.
Conditions
- Cocaine Abuse
- Cocaine-Related Disorders
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Texas
collaborator OTHER -
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Frederick G. Moeller, PhD · University of Texas
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Impulsivity, Neural Deficits and Cocaine Addiction
NCT00744601 ·Status: COMPLETED
-
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
NCT00015223 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
NCT00218075 ·Status: COMPLETED ·Phase: PHASE2
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
NCT01030692 ·Status: COMPLETED ·Phase: PHASE1
-
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
NCT02080819 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Remediation for Cocaine Dependence
NCT01393457 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Treatment for Cocaine-Alcohol Dependence - 1
NCT00218569 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
NCT01739192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence
NCT00123383 ·Status: UNKNOWN ·Phase: PHASE2
-
Dopamine Rhythms in Health and Addiction
NCT02233829 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Modafinil for the Treatment of Cocaine Dependence - 1
NCT00100100 ·Status: COMPLETED ·Phase: PHASE2
-
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
NCT00713583 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1
NCT00218387 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Caffeine and Cocaine
NCT00733993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
NCT00514202 ·Status: TERMINATED ·Phase: PHASE2
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
NCT02896712 ·Status: COMPLETED ·Phase: PHASE2